Angus Alchemy, the county’s newest distillery known for its exceptional moonshine and Scotland’s finest spirits, has proudly announced an exciting collaboration. The Carnoustie based distillery has teamed up with My Name'5 Doddie Foundation to unveil their latest creation, 'Mistaken Identity' Moonshine.

This exciting partnership comes just in time for the highly anticipated Rugby World Cup, promising a unique and flavourful way for fans to show their support for a crucial cause.

The moniker "Mistaken Identity" pays homage to Doddie's hilarious defence during the 1997 Lions Tour to South Africa when he faced allegations of violating a night time curfew.

Together with Doddie’s family, Angus Alchemy has created a unique, much-loved flavour for Doddie, banoffee pie, and will be donating £20 from every bottle to the charity.

Commenting on this collaboration, Campbell Archibald, Distiller of Divergence at Angus Alchemy, expressed his enthusiasm: "We are thrilled to partner with My Name'5 Doddie Foundation to create 'Mistaken Identity' Moonshine. This project represents our commitment to making a meaningful impact in the fight against motor neuron disease. We invite rugby fans and spirit enthusiasts alike to join us in supporting this vital cause."

Paul Thompson, Director of Fundraising at My Name’5 Doddie Foundation, also shared his thoughts on this exciting endeavour: "We are grateful for Angus Alchemy's support and their innovative approach to fundraising. 'Mistaken Identity' Moonshine is a fantastic way for people to get involved and contribute to our mission of finding a cure for MND. Together, we can make a difference."

'Mistaken Identity' Moonshine is available to purchase online now from the Angus Alchemy website.

Rugby fans and spirit connoisseurs are encouraged to grab a bottle and raise a glass to support My Name’5 Doddie Foundation as they cheer on their favourite teams during the Rugby World Cup.

More news & stories

View all
 picture
Research
23 Sep 2026

Topline announcement of Phase 3 trial results for FUS-MND appear promising

Yesterday, the companies Otsuka and Ionis announced the results of their Phase 3 trial of the genetic therapy, ulefnersen. Ulefnersen targets a rare form of MND…
Read more
 picture
MND stories Research
14 Sep 2026

R.A.C.E. to Diagnose: New training programme to speed up MND diagnosis

For Andy Vaughton, receiving a motor neuron disease (MND) diagnosis in 2021 finally provided an answer for symptoms he had been struggling with for several years.…
Read more
 picture
Fundraising MND stories
10 Sep 2026

"I love you, and this is for you": Cammy cycles over 1,000 miles in memory of his Dad

This year, Cammy Jones has taken on two long-distance cycling challenges for My Name’5 Doddie Foundation: Doddie’s Triple Crown, which saw him ride from Melrose…
Read more
Bell icon

Join our Newsletter!

By subscribing, you confirm that you agree with our terms and conditions.